Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Accord Healthcare Inc. with status Current. The shortage was first posted on 04/10/2020. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Accord Healthcare Inc.
- Package NDC
- 16729-239-93
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)
- Initial Posting
- 04/10/2020
- Revised Date
Reason
Discontinuation of the manufacture of the drug